Friday, February 23, 2018 5:42:17 PM
All extremely promising. If we can produce the best in class Haemophilia gene therapy, big market.
DLBCL and 2nd Car T, Prosavin etc. Happy days indeed.
HTTP://www.oxfordbiomedica.co.uk/system/files/corporate-presentations/BIVV%20Annoucement%20AnalystPresentation.pdf
There's also a webcast to go with it:
HTTP://www.oxfordbiomedica.co.uk/system/files/webcasts-and-audios/Conf%20call%20150218.mp3
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM